Home » Topics » BioWorld Science

BioWorld Science
RSS

Chinook Therapeutics divulges LDHA inhibitors

Dec. 13, 2021

Targeting Tet1 leads to acute antiseizure effects in rats

Dec. 13, 2021

Sironax synthesizes RIPK1 inhibitors

Dec. 13, 2021

Roche divulges new cGAS inhibitors

Dec. 13, 2021

TYK Medicines patents RET inhibitors

Dec. 13, 2021

AG-01 shows antitumor efficacy in models of triple-negative breast cancer

Dec. 13, 2021

CHMP7 as therapeutic target in sporadic and C9orf72 ALS

Dec. 13, 2021

NextVivo launches to develop immune organoid technology platform

Dec. 10, 2021

CRISPR-Cas9 gRNA system eliminates diverse proviral HIV-1 strains

Dec. 10, 2021

Totus receives financing to advance TOS-358 drug program for cancer

Dec. 10, 2021

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for June 1, 2026.
TROP2 ADCs progress into first-line for lung, breast cancers
BioWorld
Multiple updates on TROP2-directed antibody-drug conjugates (ADCs) for lung and breast cancers highlight both progress made and opportunities for improvement for...
New evidence links autoimmunity to long COVID symptoms
BioWorld
Recent findings are reshaping current understanding of the post-infection landscape of SARS-CoV-2. Although previous studies had already suggested that...
Breakthrough as GSK’s bepirovirsen clears 19% of chronic hep B infections
BioWorld
GSK plc has announced a breakthrough in the treatment of chronic hepatitis B, reporting a functional cure rate of 19% across two phase III trials of its antisense...
BMS’ mezigdomide doubles PFS in multiple myeloma
BioWorld
Bristol Myers Squibb Co. disclosed in March 2026 that the phase III portion of the seamless phase II/III Successor-2 study testing mezigdomide in combination with...